Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2021 | Impact of NGS on breast cancer diagnosis and treatment

Andrew A. Davis • 30 Nov 2021
SABCS 2021
Breast Cancer Alpelisib

Andrew A. Davis, MD, Washington University School of Medicine, St. Louis, MO, provides an overview of the utility of next-generation sequencing on cancer diagnosis and treatment, highlighting its use in identifying patients likely to respond to targeted therapies. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

More from Andrew A. Davis

1:22
Role of ctDNA in MRD
Andrew A. Davis • 30 Nov 2021
1:51
Invasive lobular carcinoma at SABCS 2021
Andrew A. Davis • 30 Nov 2021
2:20
Genome-wide ctDNA assessment predicts outcome and resistance in HR+/HER2- MBC treated with CDK4/6i
Andrew A. Davis • 30 Nov 2021

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals